Avanos Medical, Inc. Announces Second Quarter 2018 Results, Raises Full-Year 2018 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 31c, Revenues Beat; Boosts FY18 EPS, Sales Growth Guidance
August 7, 2018 7:18 AM EDTAvanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.48, $0.31 better than the analyst estimate of $0.17. Revenue for the quarter came in at $160.9 million versus the consensus estimate of $157.14 million.
Second quarter net sales from continuing operations, or Medical Device sales, were $161 million, an 8 percent increase from the prior year. On a constant currency... More